We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
+$87.1M
(+7.1%)
Cap. Flow
-$6.99M
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
287
New
16
Increased
110
Reduced
104
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Growth ETF
VUG
|
+$3M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$2.95M |
| 3 |
Schwab U.S Small- Cap ETF
SCHA
|
+$1.7M |
| 4 |
Palo Alto Networks
PANW
|
+$1.46M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.68M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.64M |
| 3 |
Honeywell
HON
|
+$3.39M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.79M |
| 5 |
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Financials | 11.09% |
| 3 | Healthcare | 7.57% |
| 4 | Communication Services | 6.46% |
| 5 | Industrials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Warner Bros
WBD
$64.6B
| $97.6K | 0.01% |
11,182
-783
| -7% | -$7.55K |
|
|
IGR
277
CBRE Global Real Estate Income Fund
IGR
$712M
| $53.8K | ﹤0.01% |
+10,000
| New | +$52.3K |
|
278
Standard BioTools
LAB
$326M
| $35.2K | ﹤0.01% |
+13,002
| New | +$31.4K |
|
279
Personalis
PSNL
$1.26B
| $22.9K | ﹤0.01% |
15,373
| – | – |
|
|
AKTS
280
DELISTED
Akoustis Technologies Inc
AKTS
| $21.6K | ﹤0.01% |
36,502
| – | – |
|
|
VIRX
281
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $14.3K | ﹤0.01% |
14,000
| – | – |
|
|
TCON
282
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $5.59K | ﹤0.01% |
650
| – | – |
|
283
Halozyme
HALO
$9.72B
| – | – |
-8,775
| Closed | -$324K |
|
284
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| – | – |
-12,296
| Closed | -$136K |
|
285
Vertex Pharmaceuticals
VRTX
$121B
| – | – |
-528
| Closed | -$215K |
|
286
Zscaler
ZS
$23B
| – | – |
-906
| Closed | -$201K |
|
|
SLGC
287
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-11,714
| Closed | -$29.6K |
|
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q1 2024 Portfolio in Review
As of Q1 2024, HoyleCohen held 287 positions worth $1.31B, up 7.1% from $1.22B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HoyleCohen's Q1 2024 filing shows 16 new, 110 increased, 104 reduced and 5 closed positions. Its largest new stake was BlackRock Taxable Municipal Bond Trust: 46,400 shares worth $758K. The largest sale was Apple, an estimated $5.68M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- HoyleCohen's largest Q1 2024 buy was BlackRock Taxable Municipal Bond Trust: 46,400 shares worth $758K.
- HoyleCohen added most to Vanguard Growth ETF in Q1 2024, an estimated $3M increase.
- HoyleCohen's biggest Q1 2024 reduction was Apple, cutting an estimated $5.68M.
- HoyleCohen fully exited Halozyme in Q1 2024, selling an estimated $324K.
- HoyleCohen's ten largest holdings make up 31% of its $1.31B portfolio in Q1 2024.
- HoyleCohen opened 16 new positions and closed 5 in Q1 2024.
- HoyleCohen's portfolio value rose 7.1% quarter-over-quarter to $1.31B.
Based on HoyleCohen's 13F filing for Q1 2024, filed 15 May 2024.